DURECT Corporation Revenue and Competitors
Estimated Revenue & Valuation
- DURECT Corporation's estimated annual revenue is currently $35M per year.
- DURECT Corporation's estimated revenue per employee is $289,256
- DURECT Corporation's total funding is $62.5M.
Employee Data
- DURECT Corporation has 121 Employees.
- DURECT Corporation grew their employee count by 3% last year.
DURECT Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Patent Counsel | Reveal Email/Phone |
2 | VP, Birmingham Operations | Reveal Email/Phone |
3 | VP Pharmaceutical Development | Reveal Email/Phone |
4 | SVP Operations & Corporate Quality Assurance | Reveal Email/Phone |
5 | VP Clinical and Regulatory Affairs | Reveal Email/Phone |
6 | EVP, R&D Business Development & Principal Scientist | Reveal Email/Phone |
7 | VP Regulatory Affairs | Reveal Email/Phone |
8 | VP, Business Development, Commercial, Medical Affairs | Reveal Email/Phone |
9 | VP Finance and Controller | Reveal Email/Phone |
10 | Executive Director, Product Development | Reveal Email/Phone |
DURECT Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is DURECT Corporation?
DURECT Corporation is developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. The Company's pharmaceutical systems combine engineering and delivery technology from the drug delivery and medical device industries with its proprietary pharmaceutical and biotechnology drug formulations. By integrating these technologies, the Company is able to control the rate and duration of drug administration as well as target the delivery of the drug to its intended site of action, allowing its pharmaceutical systems to meet the special challenges associated with treating chronic diseases or conditions.
keywords:N/A
$62.5M
Total Funding
121
Number of Employees
$35M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DURECT Corporation News
CUPERTINO, Calif., July 29, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2021 and provided a corporate update. Q2 2021 Accomplishments: We expanded the number of U.S. clinical trial sites to 26 in the Phase 2b AH ...
Other Companies in Cupertino
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $37.5M | 123 | 8% | N/A |
#2 | $33.8M | 125 | 30% | N/A |
#3 | $18.7M | 129 | 22% | N/A |
#4 | $18.9M | 130 | 7% | $95M |
#5 | $19M | 131 | 3% | N/A |